Hong Kong, January 20, 2023 – (ACN Newswire) – – EC Healthcare (SEHK stock code: 2138), the largest non-hospital medical group Hong Kong*, groups from October December 2022 (“Quarterly”) increased by more than 8% compared to the same period last year.
Demand for the medical services provided by the Group remained strong, and the Group’s increasingly diversified businesses showed resilience and good momentum.The board has decided that the overall sales volume HKD 1 billion This quarter represents an increase of over 8% year-over-year. The group expects medical services sales to grow by more than 39% year-on-year.Aesthetic Medical, Beauty & Wellness Service Sales Hong Kong When macau Decreased less than 17% year-on-year, with sales of aesthetic medical and beauty and wellness services in mainland China falling less than 50% year-on-year during the fourth quarter. The decrease in aesthetic medicine and beauty and wellness services is mainly due to (1) sluggish domestic consumption due to an increase in outbound due to the lifting of inbound quarantine. (ii) a pessimistic economic outlook and weak local consumer sentiment due to high inflation and rising interest rates; (iii) Omicron outbreaks in mainland China; In addition, the sales volume of other services decreased by 8% year-on-year.
Mr Eddie TanChairman, Managing Director and Chief Executive Officer EC Healthcare “The group is pleased to see the early stages of border reopening. Hong Kong And the mainland was implemented earlier this year, and mainland visitors gradually returned. With leading brands and one-stop diversified services, the Group has always been the first choice for medical tourists. The Group has significantly strengthened its medical service capabilities while maintaining its leading position in the aesthetic medicine industry. In addition, the Group’s continued investment in IT systems and industry value chain integration has enabled the Group to seize growth opportunities and capture demand from medical tourists. The Group will pursue organic growth and mergers to provide quality, affordable, accessible and sustainable healthcare services to a wider range of customers and to enrich the Group’s closed and diverse ecosystem. and continue to grow its business through acquisitions. The Group will also further strengthen its resilience and ability to resist cyclical economic changes, further strengthening the healthcare market. ”
almost EC Healthcare
EC Healthcare teeth of Hong Kong As the largest out-of-hospital medical service provider*, it leverages its core businesses of preventive and precision medicine and is committed to developing medical artificial intelligence by integrating its multidisciplinary medical services. Underpinned by the Group’s high-end branding and quality customer service, the move aims to provide customers with safe and effective healthcare and medical services with professionalism. The Group is a constituent of the Hang Seng Composite Index and the MSCI Hong Kong Small Cap Index.
The Group is primarily engaged in the business of providing one-stop medical and healthcare services. Greater ChinaThe Group offers a full range of services and products under its well-known brands. Hong Kong With many years of sales, professional hair care center HAIR FOREST, primary care clinic re: HEALTH jointly established with health management center, vaccine center Hong Kong specialized vaccine HKPV, general outpatient clinic Tencent Doctorwork is the largest one-stop pain management center in the United States. Hong Kong New York Medical GroupComprehensive Dental Center Bayley & Jackson Dental Surgeons, EC DENTAL CARE and Health and care dental clinicAdvanced Diagnostic and Imaging Center HKAI, Oncology Center reVIVE, Day Surgery Center HKMED, Specialty Clinic PREMIER MEDICAL CENTER, SPECIALISTS CENTRAL and NEW MEDICAL CENTER, Pediatric Center PRIME CARE, Gynecologist ZENITH MEDICAL CENTER AND PRENATAL DIAGNOSIS Center, Pathlab Medical LaboratoriesEye Center VIVID EYE and EC animal hospital and an imaging center.
*According to our own research Frost and Sullivan Earnings for 2020 and 2021
For more information, please contact:
iPR Ogilvy Limited
Caris Lau / Lorraine Luke / Tim Tin
Phone: (852) 2136 6952 / 2169 0467 / 3920 7654
Fax: (852) 3170 6606
Email: ech@iprogilvy.com
Copyright 2023 ACN Newswire. All rights reserved.
© Japanese Company News, source JCN Press Release
